References
- The Expert Panel Report of the National Cholesterol Education Program Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults. Arch Intern Med 1988: 148(1): 36–69
- Lipid Research Clinics Program. The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease. JAMA 1984: 251(3): 351–64
- Lipid Research Clinics Program. The Lipid Research Clinics Coronary Primary Prevention Trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering. JAMA 1984: 251(3): 365–74
- Canner PL, Berge KG, Wenger NK, et al. Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin. J Am Coll Cardiol 1986: 8(6): 1245–55
- Shemmon D. Fish oil supplementation diminishes the flush of niacin. Presented before Internation Symposium on Drugs Affecting Lipid Metabolism. Houston: 1989 Nov
- Lavie CJ, Gau GT, Squires KW et al. Management of lipids in primary and secondary prevention of cardiovascular diseases. Mayo Clin Proc 1988: 63(6): 605–21
- Norman DJ, Ilingworth DR, Munson J, et al. Myolysis and acute renal failure in a heart-transplant recipient receiving lovastatin. (Letter) N Engl J Med 1988: 318(1): 46–7
- Chremos A. Presented before International Symposium on Drugs Affecting Lipid Metabolism. Houston: 1989 Nov
- Hildebrand R, Hepperlen T. Lovastatin and hypospermia. Ann Intern Med 1990: 112(Apr): 549
- McCaughan D. The long-term effects of probucol on serum lipid levels. Arch Intern Med 1981: 141(11): 1428–32
- Sirtori CR, Sirtori M, Calabresi L, et al. Changes in high-density lipoprotein subfraction distribution and increased cholesteryl ester transfer after probucol. Am J Cardiol 1988: 62(3): 73–6B
- Steinberg D, Parthasarathy S, Carew TE. In vivo inhibition of foam cell development by probucol in Watanabe rabbits. Am J Cardiol 1988: 62(3): 6–12B
- Frick MH, Elo O, Haapa K, et al. Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. N Engl J Med 1987: 317(20): 1237–45
- The Lovastatin Study Group III. A multicenter comparison of lovastatin and cholestyramine therapy for severe primary hypercholesterolemia. JAMA 1988: 260(3): 359–66
- Yetiv JZ. Clinical applications of fish oils. JAMA 1988: 260(5): 665–70
- Choice of cholesterol-lowering drugs. Med Lett Drugs Ther 1988: 30(774): 81–4
- Phillipson BE, Rothrock DW, Connor WE, et al. Reduction of plasma lipids, lipoproteins, and apoproteins by dietary fish oils in patients with hypertriglyceridemia. N Engl J Med 1985: 312(19): 1210–6
- Davidson M, Dugan L, Drennan K, et al. Combination marine, oil and lovastatin therapy for familial combined hyperlipidemia. Presented before Internation Symposium on Drugs Affecting Lipid Metabolism. Houston: 1989 Nov
- Vega GL, Grundy SM. Comparison of lovastatin and gemfibrozil in normolipidemic patients with hypoalphalipoproteinemia. JAMA 1989: 262(22): 3148–53